Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1

Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1

Background: We aimed to establish an acute treatment protocol to increase serum vitamin D, evaluate the effectiveness of vitamin D3 supplementation, and reveal the potential mechanisms in COVID-19. Methods: We retrospectively analyzed the data of 867 COVID-19 cases. Then, a prospective study was con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mustafa Sait Gönen, Merve Alaylıoğlu, Emre Durcan, Yusuf Özdemir, Serdar Şahin, Dildar Konukoğlu, Okan Kadir Nohut, Seval Ürkmez, Berna Küçükece, İlker İnanç Balkan, H. Volkan Kara, Şermin Börekçi, Hande Özkaya, Zekayi Kutlubay, Yalım Dikmen, Yılmaz Keskindemirci, Spyridon N. Karras, Cedric Annweiler, Duygu Gezen-Ak, Erdinç Dursun
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
SARS-CoV-2
COVID-19
vitamin D
cytokine
cathelicidin-LL37
acute respiratory failure
Nutrition. Foods and food supply
TX341-641
Acceso en línea:https://doaj.org/article/fb5f9c30585348a2ad4b4e547856908e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/fb5f9c30585348a2ad4b4e547856908e

Ejemplares similares